LY9 and hematopoietic and lymphoid cell neoplasm: Using flow cytometry, de la Fuente et al. (2001) analyzed the expression of SLAMF3/CD229 in normal human leukocyte populations, hematopoietic cancer cell lines, and several samples from patients with B cell malignancies [52].